Endocrine manifestations of chronic kidney disease and their evolving management: A systematic review
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Endocrine manifestations of chronic kidney disease and their evolving management: A systematic review
Authors
Keywords
-
Journal
DM DISEASE-A-MONTH
Volume -, Issue -, Pages 101466
Publisher
Elsevier BV
Online
2022-08-12
DOI
10.1016/j.disamonth.2022.101466
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Emerging cross-talks between chronic kidney disease–mineral and bone disorder (CKD–MBD) and malnutrition–inflammation complex syndrome (MICS) in patients receiving dialysis
- (2022) Shunsuke Yamada et al. Clinical and Experimental Nephrology
- Folic Acid and Vitamin B12 Administration in CKD, Why Not?
- (2019) Irene Capelli et al. Nutrients
- A new nutritional risk index for predicting mortality in hemodialysis patients: Nationwide cohort study
- (2019) Eiichiro Kanda et al. PLoS One
- The interplay between mineral metabolism, vascular calcification and inflammation in Chronic Kidney Disease (CKD): challenging old concepts with new facts
- (2019) Carla Viegas et al. Aging-US
- Management of Osteoporosis in CKD
- (2018) Pascale Khairallah et al. Clinical Journal of the American Society of Nephrology
- Klotho and endocrine fibroblast growth factors: marker of chronic kidney disease progression and cardiovascular complications?
- (2018) Makoto Kuro-o NEPHROLOGY DIALYSIS TRANSPLANTATION
- Malnutrition in Chronic Kidney Disease
- (2018) Franca M. Iorember Frontiers in Pediatrics
- Fibroblast growth factor 21 in chronic kidney disease
- (2018) Paulo Giovanni de Albuquerque Suassuna et al. JOURNAL OF NEPHROLOGY
- The Emerging Role of Nutritional Vitamin D in Secondary Hyperparathyroidism in CKD
- (2018) Chien-Lin Lu et al. Nutrients
- Management of Osteoporosis in Chronic Kidney Disease
- (2017) Kosaku Nitta et al. INTERNAL MEDICINE
- Iron overload in myelodysplastic syndromes (MDS)
- (2017) Norbert Gattermann INTERNATIONAL JOURNAL OF HEMATOLOGY
- Effects of Ferric Citrate in Patients with Nondialysis-Dependent CKD and Iron Deficiency Anemia
- (2017) Steven Fishbane et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Executive summary of the 2017 KDIGO Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update: what’s changed and why it matters
- (2017) Markus Ketteler et al. KIDNEY INTERNATIONAL
- Association between circulating fibroblast growth factor 21 and mortality in end-stage renal disease
- (2017) Marina Kohara et al. PLoS One
- An overview on safety issues related to erythropoiesis-stimulating agents for the treatment of anaemia in patients with chronic kidney disease
- (2016) Lucia Del Vecchio et al. Expert Opinion On Drug Safety
- A 12-Week, Double-Blind, Placebo-Controlled Trial of Ferric Citrate for the Treatment of Iron Deficiency Anemia and Reduction of Serum Phosphate in Patients With CKD Stages 3-5
- (2015) Geoffrey A. Block et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Iron Chelation in Thalassemia Major
- (2015) Caterina Borgna-Pignatti et al. CLINICAL THERAPEUTICS
- Insulin Resistance as a Therapeutic Target for Chronic Kidney Disease
- (2015) Daniel Teta JOURNAL OF RENAL NUTRITION
- Emerging Liver–Kidney Interactions in Nonalcoholic Fatty Liver Disease
- (2015) Giovanni Musso et al. TRENDS IN MOLECULAR MEDICINE
- Insulin stimulates SGLT2-mediated tubular glucose absorption via oxidative stress generation
- (2015) Nobutaka Nakamura et al. Diabetology & Metabolic Syndrome
- Pioglitazone Improves Fat Distribution, the Adipokine Profile and Hepatic Insulin Sensitivity in Non-Diabetic End-Stage Renal Disease Subjects on Maintenance Dialysis: A Randomized Cross-Over Pilot Study
- (2014) Anne Zanchi et al. PLoS One
- Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement
- (2013) Francesco Locatelli et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Chronic Kidney Disease, Insulin Resistance, and Incident Diabetes in Older Adults
- (2012) H. Pham et al. Clinical Journal of the American Society of Nephrology
- Pilot Study of Circulating Prolactin Levels and Endothelial Function in Men With Hypertension
- (2011) K. S. Stamatelopoulos et al. AMERICAN JOURNAL OF HYPERTENSION
- Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease
- (2011) N. Itoh et al. JOURNAL OF BIOCHEMISTRY
- Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline
- (2011) Shlomo Melmed et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Erythropoietin-stimulating Agents in Chronic Kidney Disease: A Response to Hyporesponsiveness
- (2011) Patrick S. Parfrey SEMINARS IN DIALYSIS
- Mineral and bone disorders in chronic kidney disease and end-stage renal disease patients: new insights into vitamin D receptor activation
- (2011) Jordi Bover et al. Kidney International Supplements
- Insulin Resistance and Protein Energy Metabolism in Patients with Advanced Chronic Kidney Disease
- (2010) Edward D. Siew et al. SEMINARS IN DIALYSIS
- The effects of ω3 fatty acids and coenzyme Q10 on blood pressure and heart rate in chronic kidney disease: a randomized controlled trial
- (2009) Trevor A Mori et al. JOURNAL OF HYPERTENSION
- Factors Predicting the Near-Final Height in Growth Hormone-Treated Children and Adolescents with Chronic Kidney Disease
- (2008) Richard Nissel et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Vitamin D levels and patient outcome in chronic kidney disease
- (2008) Pietro Ravani et al. KIDNEY INTERNATIONAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started